The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.
May 8th 2024
Findings suggest the potential prognostic value of time-averaged serum uric acid for predicting disease progression in IgAN.
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
CBT-I, Trazodone Ineffective at Improving Insomnia for Patients on Hemodialysis
January 18th 2024Investigators observed no change in Insomnia Severity Index scores from baseline to weeks 7 and 25 with CBT-1, trazodone, or placebo, suggesting these insomnia treatment options are not effective for patients undergoing hemodialysis.
Clinical, Prognostic Factors Affecting Concurrent IgAN and Membranous Nephropathy Outcomes
January 15th 2024Results of the retrospective study suggested blood pressure, serum IgA, potassium, and segmental glomerulosclerosis may be predictive of the rapid progression of renal endpoints in patients with concurrent IgAN and membranous nephropathy.
Risk Factors for IgA Nephropathy Recurrence After Kidney Transplant
January 10th 2024Younger age at the time of kidney transplantation, faster progression to end-stage renal disease, a history of kidney transplantation, and no induction therapy were associated with IgAN recurrence, which was linked to poorer graft survival.
Impact of Early Versus Late CRRT Initiation in Children and Young Adults, with Katja Gist, DO
January 8th 2024We sat down with Katja Gist, DO, for further insight into the use of continuous renal replacement therapy in children and young adults, spotlighting the importance of timing to therapy initiation.
SGLT-2is Mitigate Risk of Cardiovascular, Kidney Diseases in Patients with Type 2 Diabetes and AKD
January 4th 2024Compared to nonusers, patients with type 2 diabetes and acute kidney disease administered SGLT-2is had a significantly lower risk of mortality, major adverse kidney events, and major adverse cardiovascular events.
Study Details Consequences of Delayed CRRT Initiation in Children, Young Adults
January 2nd 2024Each 1-day delay in continuous renal replacement therapy initiation was associated with 3% greater odds of major adverse kidney events at 90 days, including mortality, dialysis dependence, and persistent kidney dysfunction.
Cardiology Case Report: Missed Hemodialysis
December 23rd 2023This cardiology case report from Brady Pregerson, MD, features a man in his mid-30s brought by ambulance after 3-4 days of peripheral edema and generalized weakness after a missed dialysis appointment. Can you determine the correct diagnosis?
Study Supports the Efficacy, Safety of Ravulizumab for Patients with IgA Nephropathy
November 16th 2023The ravulizumab group had a proteinuria reduction of 40.3% while the placebo group had a reduction of 10.9% by week 26, highlighting ravulizumab’s effectiveness in treating patients with IgA Nephropathy.
FDA Approves Defencath to Reduce Catheter Bloodstream Infections in Adults Receiving Hemodialysis
November 15th 2023On November 15, 2023, the FDA approved Defencath. The new drug can reduce catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter.
Kidney Week 2023: Evolving Recognition of Cardiovascular, Kidney, and Metabolic Disease
November 7th 2023Check out perspective from a pair of ASN Kidney Week 2023 interviews with leading trialists discussing the evolution of cardiovascular-kidney-metabolic syndrome and how pharmacotherapy has propelled the growing recognition.